For radiation delivery tracking systems that monitor intrafraction prostate motion, generalized departmental threshold protocols may be used. The purpose of this study is to determine whether predefined action thresholds can be generally applied or if patient-specific action thresholds may be required. Software algorithms were developed in the MatLab (The Mathworks Inc., Natick, MA) software environment to simulate shifts of the patient structure set consisting of prostate, bladder, and rectum. These structures were shifted by 1/2 10 mm in each direction in 1 mm increments to simulate displacements during treatment, without taking into consideration organ deformity. Dose-volume data at each shift were plotted and analyzed. A linear relationship was observed between planning dose-volume parameters and shifted dose-volume parameters. For a 5 mm anterior shift, it was observed that individual rectal V70 values increased by absolute magnitudes of 6-15%, dependent on the planning rectal V70 of each patient. Likewise, for a 5 mm inferior shift, individual bladder V70 values increased by 1-14%, dependent on planning bladder V70. This linear relationship was observed for all levels of shifts up to 10 mm. Since rectum and bladder dose-volume changes due to patient shifts are dependent on dose-volume parameters, this study suggests that patient-specific action thresholds may be necessary.
Introduction
The clinical objective of radiation therapy (RT) is to maximize tumor control while minimizing the risk of toxicity to nearby normal tissue (1). In the radiotherapeutic management of localized prostate cancer, multiple prospective studies have reported improved biochemical disease control outcomes with escalating radiation dose (2-8). However, due to the proximity of the bladder and rectum to the target volume, dose escalation may increase late toxicities to these organs. In more recent years, the increased utilization of intensity modulated radiation therapy (IMRT) for dose-escalated prostate therapy appears to have mitigated some of this late toxicity risk (9-11). However, the increased dose conformity of IMRT may also impose added risk of target miss due to intrafractional prostate motion.
In order to accurately deliver these highly conformal dose distributions onto the prostate while accounting for intrafractional prostatic motion, the Calypso 4D Localization System (Calypso Medical Technologies Inc., Seattle, WA) has been developed as a real-time target tracking system (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) . Prior to the initiation of radiotherapy, three Calypso electromagnetic beacon transponders are implanted into the prostate gland as an outpatient procedure (23, 24) . During treatment, the system's electromagnetic array is placed directly over the implanted beacon transponders and is activated. Once activated, the beacon transponders emit a unique electromagnetic signal which is then detected by the array and used to determine the location of the transponders relative to the isocenter. Any offsets from the planned beacon transponder coordinates are then calculated in the x, y, and z axes and displayed for the therapist to execute. The treatment beam is then activated, and the Calypso system provides continuous feedback on the position of the beacon transponders, therefore allowing for real-time target tracking of displacements that exceed a given value specified by each institution (14) . Target tracking is accurate within 1.5 mm (12).
The Calypso system allows institutions to select predefined action thresholds, which are defined as the maximum allowed target excursions along any axis from the setup coordinates during delivery of the treatment fraction (13, 15, 17) . If intrafraction prostate motion is below the predefined threshold, then no action is taken; however, if intrafraction prostate motion is above the threshold, an alert is triggered. Once the alert is triggered, treatment may be paused, and the therapist may wait a predetermined time (usually 30-90 seconds) to allow the target to return within the threshold limits before repositioning the patient (17).
Predefined action thresholds of 3 mm, 5 mm, and 7 mm have been reported with use of the Calypso system. These predefined action thresholds are not patient-specific, but are generalized. Moreover, these thresholds currently do not take into account the variation in bladder and rectum volumes irradiated due to positional variations that are less than the given threshold. For example, if a 5 mm threshold is used, treatment will continue uninterrupted as long as intrafraction motion does not exceed 5 mm. This means that, for displacements less than the 5 mm threshold, it is possible that larger volumes of the bladder and rectum may be irradiated than were planned. This additional volume of bladder and rectum irradiated may be significant, and action threshold selection may need to consider the dose-volume consequences of such positional variations.
The goals of the present study are twofold: first, to quantify the potential dosimetric significance of using predefined action thresholds of 3 mm versus 5 mm versus 7 mm; second, to determine whether predefined action thresholds can be generally applied or if patient-specific action thresholds that take into account planning dose volume histogram (DVH) data may be required. The dosimetric effects of using these different thresholds were evaluated by simulating rigid structure translations that might not mimic true structure deformations that occur in a clinical setting; therefore, the present study is theoretical, but still worthy for consideration.
Materials and Methods

Patient Demographics
The computed tomography (CT) scans of 30 consecutive patients diagnosed with Stage II (AJCC, 2002) prostate adenocarcinoma were obtained in this Institutional Review Board (IRB) approved retrospective study. The patients' ages ranged from 55 to 79 years, with a median age of 70 years. The prescribed dose for each patient was 78 Gy in 2 Gy fractions delivered over 8 weeks.
Treatment Planning
All patients were previously treated in the supine position with 5-9 beams of uniformly spaced segmental IMRT. The beam energy was 6 MV, 23 MV, or a combination of the two. All patients were planned by the same physician using XiO (Elekta-CMS Software Inc., Maryland Heights, MO) software. Planning was performed on CT scans, with a slice thickness/table index of 3 mm. Bladder and rectal contrast were not used in the planning CT scans. However, a urinary catheter was inserted into the rectum as a visual marker. The prostate, rectum, and bladder were each contoured as whole organ structures, and the rectum was defined anatomically from the anus to the sigmoid flexure. The planning target volume (PTV) expansion was 1 cm in all directions except posterior, which was 0.7 cm. The prostate D100 (the radiation dose received by 100% of the prostate volume) was always planned at 100% of the prescribed dose (78 Gy). Maximum rectal planning constraints used in the clinic were V50 (the percent volume of rectum receiving 50 Gy or more) , 55%, V70 , 25%, and V75 , 5% (25). Maximum bladder constraints were V50 , 50% and V70 , 25%. In order to ensure adequate dose coverage to the tumor volume, the planning bladder V70 exceeded 25% for two patients (maximum value of 26%), and planning rectum V75 exceeded 5% for 13 patients (maximum value of 13%).
Software Development
In order to quantify the dosimetric significance of using different action thresholds, it was necessary to evaluate the changes in volumes of the rectum and bladder irradiated due to positional variations at or below threshold. Since this is a retrospective study, the positional variations were achieved by algorithms that were written in the MatLab (The Mathworks Inc., Natick, MA) software environment to simulate shifts of the patient structure set (prostate, rectum, and bladder). The algorithms shifted each of these structures by 1/2 10 mm in 1 mm increments in each of the six anatomical directions (right, left, superior, inferior, posterior, anterior) to simulate displacements during treatment.
Simulation of Structure Shifts
After obtaining the CT simulation scans of each of the 30 patients, the patient CT simulation images, structure data, and dose data were extracted from the planning database and imported into the MatLab program that was previously developed. The algorithm shifted the prostate, rectum, and bladder relative to the dose distribution 1/2 10 mm in 1 mm increments in each direction. Each shift represented a theoretical rigid translation that assumed that the entire structure set (prostate, rectum, bladder) shifted as an entity. Daily variations in bladder or rectum deformity due to filling or the passage of gas were not considered. At each shift, DVHs of each structure were calculated. Dose-volume changes due to each shift at specific points on a DVH, such as rectal V50, V70, V75, and bladder V50 and V70, were recorded as these are the points used in the clinic for planning constraints.
Data Analysis
For each shift in every direction, the shifted rectal V50 was plotted against the planning rectal V50. This was done for every patient at 1 mm intervals up to 10 mm. The same was done for the rectal V70 and V75. Likewise, for each shift in every direction, the shifted bladder V50 was plotted against the planning V50. Similarly, this was done for each patient at 1 mm intervals. The same was done for the bladder V70. A best linear fit was then performed in Excel (Microsoft Corporation, Redmond, WA) in order to evaluate the relationship, if any, between planning dose-volume rectum and bladder parameters and dose-volume parameters due to a given shift. The slopes of these linear fits at each shift were compared.
Results and Discussion
Using changes in rectal V70 due to 3 mm, 5 mm, and 7 mm shifts as an example, Figures 1A to 1C , respectively, represent graphs of the best linear fits of shifted rectal V70 plotted against planning rectal V70 for each patient. Each vertical collection of points represents changes in a single patient's planning V70 due to shifts in each of the six principal directions, assuming the worst case scenario in which the shift occurs during every fraction throughout the patient's course of treatment. As expected, anterior shifts had the greatest effect on increasing rectal V70, and posterior shifts had the greatest effect on decreasing rectal V70. Superior, inferior, left, and able to tolerate a 5.9% increase in rectal V70, and therefore may be able to tolerate a 5 mm action threshold. Patient B, on the other hand, may not be able to tolerate an absolute increase in rectal V70 by 13.0% more than expected at the time of planning, and therefore may need a smaller action threshold than 5 mm.
Similar trends were observed for changes in bladder DVH parameters due to simulated shifts. As an example, Figures  2A to 2C represent graphs of the best linear fits of shifted bladder V70 plotted against planning bladder V70 for 3 mm, 5 mm, and 7 mm thresholds. Again, each vertical collection of points represents changes in a single patient's planning V70 due to given shifts in each of the six anatomical directions, assuming the worst case scenario in which the structure set shifts nearly above threshold during every fraction throughout the patient's course of treatment. Whereas anterior and posterior shifts had the greatest effect on rectal DVH parameters, inferior shifts had the greatest effects on increasing bladder V70, and superior shifts had the greatest effects on decreasing bladder V70. This trend was observed for all bladder DVH parameters (V50, V70). Similar to the rectum, as the threshold increases, the magnitude of the slopes of the best fit lines for each shift increase as well, meaning that larger thresholds results in larger volume of bladder irradiated. This trend can be seen in Table II . As the inferior shift increases, the slopes of the inferior shift best fit lines increase accordingly.
Similar to the rectum, the bladder has a linear relationship between planning V70 and shifted V70. Larger planning bladder V70 values correlate with larger absolute increases or decreases in V70 due to inferior or superior shifts, respectively. This is best seen with an example. In Figure 2B , patient A was planned at a bladder V70 value of 2.3%. If patient A shifts in the inferior direction by 5 mm throughout each fraction during the course of his treatment, the new bladder V70 value would be 3.8%, for an absolute increase in V70 of only 1.5%. Patient B, however, was planned at a much larger bladder V70 value of 26.1%. If patient B shifts inferiorly 5 mm during every fraction throughout the course of his treatment, the new bladder V70 value would be 38.2%, an absolute increase in bladder V70 of 12.1%. Since patient A's bladder V70 could increase by only 1.5% due to a 5 mm inferior shift, but patient B's bladder V70 could increase by 12.1% due to the same inferior shift, patient A may be able to tolerate a 5 mm threshold, but patient B may need a smaller threshold.
Previous studies have suggested that institutions using the Calypso 4D Localization System can choose action thresholds with regards to intrafractional prostate displacements during radiation delivery such as 3 mm, 5 mm, and 7 mm (13, 15, 17) . It was suggested that, for prostate displacements beyond a predefined action threshold, a notification alert is right shifts had little effect on rectal V70, and best fit lines for shifts in these directions deviated little from the identity line. This trend was observed for all rectal DVH parameters (V50, V70, V75) at any of the simulated shifts from 1 mm to 10 mm. To quantify the potential dosimetric significance of using a 3 mm threshold versus a 5 mm or 7 mm threshold, it can be seen that as the threshold increases, the slope of the anterior shift line gets steeper, and the slope of the posterior shift line flattens out. These results confirm that using larger thresholds irradiates larger volumes of rectum. This trend was seen for each of the rectal DVH parameters. Table I shows that, for each DVH point, as the anterior shift increases, the slopes of the best linear fits of shifted rectal DVH parameter plotted against the planning rectal DVH parameter increase accordingly.
For each threshold, there is a linear relationship between planning V70 and shifted V70. Larger planning V70 values correlate with potentially larger absolute increases or decreases in rectal V70 due to a given anterior or posterior shift, respectively. For example, in Figure 1B , patient A was planned at a rectal V70 value of 3.5%. Assuming the worst case scenario, in which the patient shifts 5 mm in the anterior direction during each fraction throughout the course of patient A's treatment, V70 increases to 9.4%, for an absolute increase in rectal V70 of 5.9%. Now consider patient B who was planned at a rectal V70 of 17.9%. If patient B shifts 5 mm in the anterior direction as did patient A in the previous example, patient B's rectal V70 increases to 30.9%, for an absolute increase in rectal V70 of 13.0%. Patient A may be In this study, by comparing the slopes of the best linear fits of shifted V70 against planning V70 for both rectum and bladder, it was confirmed that larger shifts could lead to larger increases in V70 for both rectum and bladder, meaning that larger action thresholds could potentially allow larger volumes of whole rectum and whole bladder to be irradiated (Table  I, Table II ). Since the maximum dose received by the bladder and rectum due to prostate displacements is at the outer wall of each organ, rather than at the lumenal contents, it is reasonable to assume a similar relationship for rectal wall/ bladder wall contours. Perhaps more importantly, for both rectum and bladder, it was found that there is a linear relationship between planning DVH parameters and DVH parameters due to a given shift. Since this relationship exists, and since DVH parameters at the time of planning are specific for each patient, it might be necessary to use patient-specific action thresholds that consider planning dose-volume parameters instead of using generalized thresholds.
Although this study suggests that patient-specific action thresholds may be necessary, this study has several limitations. To begin, the linear relationships derived from this triggered, treatment may be paused, and the patient may be repositioned by the therapist (17). However, these thresholds do not consider the effect of such thresholds on the volume of bladder and rectum irradiated.
patient data are only valid for structure shifts between 1 mm and 10 mm. Moreover, all simulated structure data was derived from only one CT scan per patient and does not take into account rectal and bladder deformations that may occur during the course of treatment. Going forward, future studies would monitor changes in rectal and bladder volume and shape during treatment in order to incorporate these changes in the selection of appropriate action thresholds.
Another limitation arises in the assumptions made regarding the correlation between prostate motion and rectal displacements. This study suggests that rectal positional variations during treatment could be used to assign action thresholds based on prostate displacements. It has therefore been assumed that as the prostate displaces by a given distance during treatment, the rectum displaces by the same distance, regardless of direction. Under this assumption, anterior prostate displacements should correlate with anterior rectal displacements, which should increase the volume of rectum irradiated. In other words, this study assumed that the prostate, rectum, and bladder displace uniformly as an intact structure set. However, it has been shown that this is not the case, and rectal variations are often unpredictable, even when there is no prostate displacement (26). Moreover, this study only considers rigid translational offsets and does not take into account deformations due to rectum and bladder filling or rotational prostate motion.
Despite these limitations, the present study is valuable in that it approaches prostate action threshold selection from a different perspective: using normal tissue dose-volume data to individualize therapy for each patient. By no means does this study put an end to the ongoing discussion regarding prostate action levels and the effects of different treatment margins. Rather, the present study is meant to provide thought provoking insight into using differences in normal tissue anatomy to individualize patient care.
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